Julie Tablet
Product Images NDC 82791-532

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Julie (NDC 82791-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Julie Products Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Package Label-principal Display Panel -1.5 mg (1 Tablet Carton Label) (Levonorgestrel Fig1)

Package Label-principal Display Panel -1.5 mg (1 Tablet Carton Label) (Levonorgestrel Fig1)
This product appears to be an emergency contraceptive in the form of a tablet. The directions instruct the user to take the tablet as soon as possible within 72 hours after unprotected sex or contraceptive failure. The tablet may also have some common side effects listed such as nausea, lower stomach pain, dizziness, and breast pain. The product is not effective in protecting against HIV or other STDs. The inactive ingredients include colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, and potato starch. The product label provides instructions and warnings, including that the product should not be used if the user has an allergy to levonorgestrel and if the user is already pregnant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.